Access cutting-edge breast cancer treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with metastatic or inoperable locally advanced breast cancer. The study will be performed in two stages. During Stage 1, four cohorts will be enrolled in parallel in this study: Cohort 1 will consist of Programmed death-ligand 1 (PD-L1)-positive participants who have received no prior systemic therapy for metastatic or inoperable locally advanced triple-negative breast cancer (TNBC)
Sponsor: Hoffmann-La Roche
Check if you qualify for this breast cancer clinical trial in Stanford, CA
If you're searching for breast cancer treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.